These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8684203)

  • 1. Changing the natural history of HIV disease.
    Feinberg MB
    Lancet; 1996 Jul; 348(9022):239-46. PubMed ID: 8684203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral dynamics in human immunodeficiency virus type 1 infection.
    Wei X; Ghosh SK; Taylor ME; Johnson VA; Emini EA; Deutsch P; Lifson JD; Bonhoeffer S; Nowak MA; Hahn BH
    Nature; 1995 Jan; 373(6510):117-22. PubMed ID: 7529365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV results in the frame. CD4+ cell turnover.
    Dimitrov DS; Martin MA
    Nature; 1995 May; 375(6528):194-5; author reply 198. PubMed ID: 7746314
    [No Abstract]   [Full Text] [Related]  

  • 4. High turnover of HIV in blood revealed by new studies.
    Cohen J
    Science; 1995 Jan; 267(5195):179. PubMed ID: 7809623
    [No Abstract]   [Full Text] [Related]  

  • 5. Report of the NIH Panel To Define Principles of Therapy of HIV Infection.
    Ann Intern Med; 1998 Jun; 128(12 Pt 2):1057-78. PubMed ID: 9652992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.
    Markowitz M; Louie M; Hurley A; Sun E; Di Mascio M; Perelson AS; Ho DD
    J Virol; 2003 Apr; 77(8):5037-8. PubMed ID: 12663814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
    Ho DD; Neumann AU; Perelson AS; Chen W; Leonard JM; Markowitz M
    Nature; 1995 Jan; 373(6510):123-6. PubMed ID: 7816094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma viral load, CD4+ cell counts, and HIV-1 production by cells.
    Levy JA; Ramachandran B; Barker E; Guthrie J; Elbeik T
    Science; 1996 Feb; 271(5249):670-1. PubMed ID: 8571134
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presenting plasma HIV RNA level and rate of CD4 T-cell decline.
    Gottlieb GS; Hawes SE; Nickle DC; Herbeck JT; Kiviat NB; Mullins JI; Sow PS
    JAMA; 2007 Feb; 297(8):805; author reply 806-7. PubMed ID: 17327518
    [No Abstract]   [Full Text] [Related]  

  • 14. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication.
    Palmer BE; Boritz E; Blyveis N; Wilson CC
    J Virol; 2002 Jun; 76(12):5925-36. PubMed ID: 12021325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 in peripheral blood monocytes: an underrated viral source.
    Zhu T
    J Antimicrob Chemother; 2002 Sep; 50(3):309-11. PubMed ID: 12205054
    [No Abstract]   [Full Text] [Related]  

  • 16. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIV infection and long-term health: therapeutically attainable?].
    Baumgarten R
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):149-53. PubMed ID: 9244657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.
    Coffin JM
    Science; 1995 Jan; 267(5197):483-9. PubMed ID: 7824947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 RNA in blood and pathogenesis of HIV infection.
    Saksela K
    Ann Med; 1995 Dec; 27(6):625-8. PubMed ID: 8652140
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.